HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The development of antisense oligonucleotide therapies for Duchenne muscular dystrophy: report on a TREAT-NMD workshop hosted by the European Medicines Agency (EMA), on September 25th 2009.

AuthorsF Muntoni, Meeting Steering Committee and TREAT-NMD Network
JournalNeuromuscular disorders : NMD (Neuromuscul Disord) Vol. 20 Issue 5 Pg. 355-62 (May 2010) ISSN: 1873-2364 [Electronic] England
PMID20347306 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Oligonucleotides, Antisense
Topics
  • Biological Therapy
  • Europe
  • Genetic Therapy
  • Guidelines as Topic
  • Humans
  • Muscular Dystrophy, Duchenne (therapy)
  • Oligonucleotides, Antisense (chemistry, therapeutic use)
  • Outcome Assessment, Health Care

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: